Your browser doesn't support javascript.
loading
World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
Diarra, Birama; Yonli, Albert Theophane; Ouattara, Abdoul Karim; Zohoncon, Theodora Mahoukèdè; Traore, Lassina; Nadembega, Christelle; Obiri-Yeboah, Dorcas; Yara, Justine; Pietra, Virginio; Ouedraogo, Paul; Bougouma, Alain; Sanogo, Rokia; Simpore, Jacques.
Afiliación
  • Diarra B; Biomolecular Research Center Pietro Annigoni (CERBA), BP 364, Ouagadougou 01, Burkina Faso.
  • Yonli AT; Laboratory of Molecular Biology and Molecular Genetics (LaBioGene) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, BP 7021, Ouagadougou 03, Burkina Faso.
  • Ouattara AK; Biomolecular Research Center Pietro Annigoni (CERBA), BP 364, Ouagadougou 01, Burkina Faso.
  • Zohoncon TM; Laboratory of Molecular Biology and Molecular Genetics (LaBioGene) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, BP 7021, Ouagadougou 03, Burkina Faso.
  • Traore L; Biomolecular Research Center Pietro Annigoni (CERBA), BP 364, Ouagadougou 01, Burkina Faso. ak.ouattara02@gmail.com.
  • Nadembega C; Laboratory of Molecular Biology and Molecular Genetics (LaBioGene) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, BP 7021, Ouagadougou 03, Burkina Faso. ak.ouattara02@gmail.com.
  • Obiri-Yeboah D; Biomolecular Research Center Pietro Annigoni (CERBA), BP 364, Ouagadougou 01, Burkina Faso.
  • Yara J; Laboratory of Molecular Biology and Molecular Genetics (LaBioGene) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, BP 7021, Ouagadougou 03, Burkina Faso.
  • Pietra V; Biomolecular Research Center Pietro Annigoni (CERBA), BP 364, Ouagadougou 01, Burkina Faso.
  • Ouedraogo P; Laboratory of Molecular Biology and Molecular Genetics (LaBioGene) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, BP 7021, Ouagadougou 03, Burkina Faso.
  • Bougouma A; Laboratory of Molecular Biology and Molecular Genetics (LaBioGene) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, BP 7021, Ouagadougou 03, Burkina Faso.
  • Sanogo R; Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
  • Simpore J; SOS Hepatitis, Ouagadougou, Burkina Faso.
Virol J ; 15(1): 121, 2018 08 06.
Article en En | MEDLINE | ID: mdl-30081915

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Vacunación / Programas de Inmunización / Hepatitis B Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Burquina Faso

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Vacunación / Programas de Inmunización / Hepatitis B Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Burquina Faso